Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders. - Moyes CR; He S; Mathieu S; Lehman SL; Francisco MT; Vardy E; Terracina G; Galstian A; Murphy MJM; Poterewicz G; Kosinski D; Yang X; et al. (Journal of medicinal chemistry, 2025)